225 related articles for article (PubMed ID: 15878666)
1. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates.
Leśnikowski ZJ; Paradowska E; Olejniczak AB; Studzińska M; Seekamp P; Schüssler U; Gabel D; Schinazi RF; Plesek J
Bioorg Med Chem; 2005 Jul; 13(13):4168-75. PubMed ID: 15878666
[TBL] [Abstract][Full Text] [Related]
2. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
4. Towards new boron carriers for boron neutron capture therapy: metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates.
Białek-Pietras M; Olejniczak AB; Tachikawa S; Nakamura H; Leśnikowski ZJ
Bioorg Med Chem; 2013 Mar; 21(5):1136-42. PubMed ID: 23357039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors.
Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W
J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Cobalt Bis(Dicarbollide)-Curcumin Conjugates for Potential Use in Boron Neutron Capture Therapy.
Dezhenkova LG; Druzina AA; Volodina YL; Dudarova NV; Nekrasova NA; Zhidkova OB; Grin MA; Bregadze VI
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889538
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy.
Al-Madhoun AS; Johnsamuel J; Barth RF; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6280-6. PubMed ID: 15342416
[TBL] [Abstract][Full Text] [Related]
10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.
Justus E; Awad D; Hohnholt M; Schaffran T; Edwards K; Karlsson G; Damian L; Gabel D
Bioconjug Chem; 2007; 18(4):1287-93. PubMed ID: 17569498
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):953-8. PubMed ID: 15308174
[TBL] [Abstract][Full Text] [Related]
15. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of boron clusters with derivatives of natural chlorin and bacteriochlorin.
Bregadze VI; Sivaev IB; Lobanova IA; Titeev RA; Brittal DI; Grin MA; Mironov AF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S101-4. PubMed ID: 19447631
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
[TBL] [Abstract][Full Text] [Related]
19. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
20. Aggregation behavior of nucleoside-boron cluster conjugates in aqueous solutions.
Matejícek P; Cígler P; Olejniczak AB; Andrysiak A; Wojtczak B; Prochazka K; Lesnikowski ZJ
Langmuir; 2008 Mar; 24(6):2625-30. PubMed ID: 18257589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
